Articles by Timo Vesikari, M.D.

1 2 3 4 5

A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months

Vesikari, Timo; Becker, Thomas; Vertruyen, Andre F.; More

Pediatric Infectious Disease Journal. 36(2):209-215, February 2017.

Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal...

Vesikari, Timo; Forsten, Aino; Bianco, Veronique; More

Pediatric Infectious Disease Journal. 34(12):e298-e307, December 2015.

A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in...

Vesikari, Timo; Brodszki, Nicholas; van Damme, Pierre; More

Pediatric Infectious Disease Journal. 34(9):992-998, September 2015.

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: ...

Vesikari, Timo; Richardus, Jan Hendrik; Berglund, Johan; More

Pediatric Infectious Disease Journal. 34(7):774-782, July 2015.

An Open-Label, Randomized Study of a 9-Valent Human Papillomavirus Vaccine Given Concomitantly with Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccines to Healthy...

Kosalaraksa, Pope; Mehlsen, Jesper; Vesikari, Timo; More

Pediatric Infectious Disease Journal. 34(6):627-634, June 2015.

Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

Sobanjo-ter Meulen, Ajoke; Vesikari, Timo; Malacaman, Edgardo A.; More

Pediatric Infectious Disease Journal. 34(2):186-194, February 2015.

Impact and Effectiveness of RotaTeq® Vaccine Based on 3 Years of Surveillance Following Introduction of a Rotavirus Immunization Program in Finland

Vesikari, Timo; Uhari, Matti; Renko, Marjo; More

Pediatric Infectious Disease Journal. 32(12):1365-1373, December 2013.

Primary Versus Secondary Failure After Varicella Vaccination: Implications for Interval Between 2 Doses

Bonanni, Paolo; Gershon, Anne; Gershon, Michael; More

Pediatric Infectious Disease Journal. 32(7):e305-e313, July 2013.

A Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C Tetanus Toxoid Conjugate Vaccine Is Immunogenic and Well-tolerated When Coadministered With Diphtheria, ...

Vesikari, Timo; Forstén, Aino; Desole, Maria Guiseppina; More

Pediatric Infectious Disease Journal. 32(5):521-529, May 2013.

Immunogenicity, Safety and Reactogenicity of a Mammalian Cell-Culture–Derived Influenza Vaccine in Healthy Children and Adolescents Three to Seventeen Years of Age

Vesikari, Timo; Block, Stan L.; Guerra, Fernando; More

Pediatric Infectious Disease Journal. 31(5):494-500, May 2012.

Immunogenicity of 10-Valent Pneumococcal Nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine When Administered as Catch-up Vaccination to Children 7 Months to 5 Years...

Vesikari, Timo; Karvonen, Aino; Korhonen, Tiina; More

Pediatric Infectious Disease Journal. 30(8):e130-e141, August 2011.

An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine Given Concomitantly...

Vesikari, Timo; Van Damme, Pierre; Lindblad, Niklas; More

Pediatric Infectious Disease Journal. 29(4):314-318, April 2010.

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

Vesikari, Timo; Wysocki, Jacek; Chevallier, Bertrand; More

Pediatric Infectious Disease Journal. 28(4):S66-S76, April 2009.

Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood...

Chevallier, Bertrand; Vesikari, Timo; Brzostek, Jerzy; More

Pediatric Infectious Disease Journal. 28(4):S109-S118, April 2009.

A Randomized, Double-Blind Study of the Safety, Transmissibility and Phenotypic and Genotypic Stability of Cold-Adapted Influenza Virus Vaccine

Vesikari, Timo; Karvonen, Aino; Korhonen, Tiina; More

Pediatric Infectious Disease Journal. 25(7):590-595, July 2006.

A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis

De Vos, Beatrice; Vesikari, Timo; Linhares, Alexandre C.; More

Pediatric Infectious Disease Journal. 23(10):S179-S182, October 2004.

1 2 3 4 5